Patalinghug, Rey .
HRN: 25-06-32 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/23/2024
MUPIROCIN 2%, 15G (TUBE)
05/23/2024
05/30/2024
TOPICAL
Apply On Wound
BID
Abscess
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes